Hopital de l'Enfant-Jesus   Report issue

Academic/Hospital Phase 2
Founded: Quebec City Canada

Organization Overview

First Clinical Trial
2006
NCT00910013
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hopital de l'Enfant-Jesus

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Hemorrhage (Phase 2)

Hemorrhage (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Preleukemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5